(Q35551180)

8 August 2017

1 reference

title

Noncholesterol-lowering effects of statins (English)

1 reference

8 August 2017

Noncholesterol-Lowering Effects of Statins (English)

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Cardiology and cardiovascular medicine

18 March 2024

main subject

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

18 March 2024

author name string

Daphne Pierre-Paul

1

1 reference

8 August 2017

Vivian Gahtan

2

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14528375

18 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

http://journals.sagepub.com/doi/pdf/10.1177/153857440303700501

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Vascular and Endovascular Surgery

18 March 2024

published in

1 reference

8 August 2017

37

1 reference

8 August 2017

301-313

1 reference

8 August 2017

5

1 reference

The evolving role of statins in the management of atherosclerosis

8 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Antiplatelet drugs. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Nucleotide receptors: an emerging family of regulatory molecules in blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

S-nitroso-glutathione inhibits platelet activation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Prevention of primary islet isograft nonfunction in mice with pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Effect of pravastatin on outcomes after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

HMG CoA reductase inhibitors and the skeleton: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Simvastatin improves fracture healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Cellular antioxidant effects of atorvastatin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440303700501

Direct effects of statins on the vascular wall

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

18 March 2024

4

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

18 March 2024

5

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Reductase inhibitor monotherapy and stroke prevention

18 March 2024

14

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

18 March 2024

21

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

18 March 2024

31

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

18 March 2024

32

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Platelet-dependent thrombin generation in patients with hyperlipidemia

18 March 2024

33

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats

18 March 2024

34

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia

18 March 2024

37

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production

18 March 2024

39

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes

18 March 2024

43

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

18 March 2024

44

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

18 March 2024

46

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

18 March 2024

47

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Direct vascular effects of HMG-CoA reductase inhibitors

18 March 2024

51

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes

18 March 2024

52

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

18 March 2024

58

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

18 March 2024

63

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells

18 March 2024

70

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

18 March 2024

71

1 reference

https://api.crossref.org/works/10.1177/153857440303700501

18 March 2024

Identifiers

0 references

1 reference